Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
FT301
print preview
bookmark
share with colleague
General Information
Company
Fate Therapeutics Inc.
Description
Wingless-type MMTV integration site family member 7A (WNT7A) analog
Molecular Target
Wingless-type MMTV integration site family member 7A (WNT7A)
Mechanism of Action
Latest Stage of Development
Preclinical
Indication
Muscular dystrophy
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information